Joshua T. Greeley v. HHS - Tdap, vasovagal syncope with residual effects (2026)
Case summary [AI summaries can sometimes make mistakes]
On February 29, 2024, Joshua T. Greeley filed a petition alleging that Tdap and HPV vaccines administered on May 24, 2022 caused vasovagal syncope with residual effects lasting more than six months.
Respondent denied that the vaccinations caused Mr. Greeley's alleged injury or any other condition.
The public stipulation does not describe the immediate syncopal event, emergency care, testing, treatment, or residual symptoms. The parties settled the case by stipulation.
On January 22, 2026, Chief Special Master Brian H. Corcoran adopted the stipulation and awarded $37,500.00 as a lump sum through counsel's IOLTA account for all damages available under the Vaccine Act.
Theory of causation
Tdap and HPV vaccines May 24, 2022 allegedly causing vasovagal syncope with residual effects; adult, exact age not stated; same-day onset. COMPENSATED by stipulation. Respondent denied causation; public stipulation lacks clinical chronology. Award $37,500. Chief SM Brian H. Corcoran; petition February 29, 2024; decision January 22, 2026.
Source PDFs
USCOURTS-cofc-1_24-vv-00319